ASBP Innovates to Get Blood Products Where They’re Needed ASAP

(951) 966-9544

  While the Armed Services Blood Program (ASBP) doesn't have an official slogan, if it did it would be "Our community is small, but our reach is great," Col. Audra Taylor said at the session," Armed Services Blood Program: Lifeline for the Frontlines: Blood Product Innovation to Support the Warfighter."  The ASBP is combat support agency comprising the U.S. Army, Navy and Air Force. But it's also a global program, with offices throughout the U.S. and the world. Taylor talked about achieving the program's goal: to push blood products closer to the point of injury through innovation. To support that effort,...

Continue reading

Filed under: 6022381797, TraumaTagged with: ,


Several trials have examined the effect of different transfusion thresholds in adult patients, but data for pediatric patients is far less frequent. A group of 38 international, multidisciplinary experts in red blood cell (RBC) transfusion management of critically ill children, organized and led by members of the Pediatric Blood Research Network (BloodNet), recently developed evidence-based and expert consensus-based recommendations for when to transfuse critically ill children. Speakers at one Annual Meeting session gave attendees an in-depth look at this initiative -- the Pediatric Critical Care Transfusion and Anemia eXpertise Initiative (TAXI). Scot Bateman, MD, of UMass Memorial Health Care, kicked...

Continue reading

Filed under: Uncategorized

Stem Cell Gene Therapy: From Bench to Therapeutics with David A. Williams


  The presentation of the Karl Landsteiner Memorial Award and Lectureship is always one of the highlights of the AABB Annual Meeting – and this year was no exception. David A. Williams, MD, senior vice president and chief scientific officer at Boston Children’s Hospital; and president of the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, fittingly began his talk by commenting on the legendary Austrian scientist’s contributions to the field. He noted Landsteiner’s profound influence on medicine, highlighting that the field of transfusion medicine, in particular, is indebted to his work. Taking us for a deep dive into the research,...

Continue reading

Filed under: 2018 AABB Annual Meeting, 7875340522, CT


In 2012, the U.S. Food and Drug Administration approved tenofovir and emtricitabine (Truvada, Gilead) as pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals. As PrEP use becomes more widespread, blood centers are increasingly likely to encounter donors who take PrEP. Monday’s Annual Meeting session “Preexposure HIV Prophylaxis in the Donor Room” presented attendees with an overview of PrEP, its effect on HIV antibody tests and the complex eligibility questions raised by the use of PrEP among prospective donors.


Filed under: 3612703463, 626-384-6678, Regulatory, UncategorizedTagged with: , , ,


The rate of Zika virus (ZIKV) among blood donors in the United States – even at the height of the 2016 epidemic – does not meet the threshold at which universal minipool nucleic acid testing (MP-NAT) or individual donation nucleic acid testing (ID-NAT) would be considered cost-effective, even if cost-effectiveness is defined as $1 million per quality-adjusted life year gained (QALY). These findings, presented by Brian Custer, PhD, from Vitalant Research Institute were based on a study led by W. Alton Russel, BS, from Stanford University. The results were presented during Monday afternoon’s oral abstract session on transfusion-transmitted infections.

(231) 719-9681

Filed under: 2018 AABB Annual Meeting, Hemovigilance, ResearchTagged with: , ,


The shelf life of platelets remains a hot topic and can sometimes be the source of controversy. When comparing the safety and quality of 5-day platelets to that of 7-day platelets, is any potential added risk of bacterial contamination worth the benefits of a longer shelf life? These issues and more were discussed during the Sunday session, "Seven-Day Platelets: Quality Implications, Safety Benefits and Implementation Challenges."

Continue reading

Filed under: 2018 AABB Annual MeetingTagged with:


Do you know Karl Landsteiners’ ABO type?  Why do we call pre-transfusion testing a “crossmatch”? These and other questions were answered by Joann M. Moulds, PhD, during her Sally Frank Memorial Award lecture. Moulds took the participants on a time travel voyage to look at how serology and AABB Standards have changed over the past 100 years. The lecture concluded with a look of what techniques serologists will be using in the future.

Continue reading

Filed under: 2018 AABB Annual Meeting, AwardsTagged with: ,

Crunching the Numbers: Insights from NBCUS and AABB’s Blood Survey

As medicine evolves, so does the way we collect and administer blood products. Speakers at the Annual Meeting session “Blood Collection and Use in the United States: Findings of the 2017 CDC National Blood Collection and Utilization Survey and the 2016 AABB Blood Survey” shared preliminary data that helps paint a picture of the blood system in the U.S.

(407) 944-6566

Filed under: (480) 526-9149, RBCs, UncategorizedTagged with: , , , , , ,